Detalles de la búsqueda
1.
Pharmacologic modulation of intracellular Na+ concentration with ranolazine impacts inflammatory response in humans and mice.
Proc Natl Acad Sci U S A
; 119(29): e2207020119, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858345
2.
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values.
Int J Mol Sci
; 25(2)2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38255810
3.
Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors.
Cardiovasc Ultrasound
; 21(1): 15, 2023 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580777
4.
PCSK9 as an Atherothrombotic Risk Factor.
Int J Mol Sci
; 24(3)2023 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36768292
5.
Smoking and Diabetes Attenuate Number of CD34+ Haematopoietic Stem Cells in Peripheral Blood of Patients with Advanced Peripheral Artery Disease.
Int J Mol Sci
; 24(20)2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37895025
6.
Stem Cell Therapy for Chronic and Advanced Heart Failure.
Curr Heart Fail Rep
; 17(5): 261-270, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783146
7.
Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6.
Biomarkers
; 19(5): 385-90, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831174
8.
Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction.
Heart Vessels
; 29(3): 313-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23712600
9.
Effects of proprotein convertase subtilisin-kexin type 9 inhibitors on inflammatory and hemostatic parameters in post myocardial infarction patients.
Eur J Pharmacol
; 963: 176232, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070635
10.
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.
Genes (Basel)
; 14(3)2023 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980904
11.
Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall.
J Clin Med
; 11(13)2022 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806908
12.
Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levels.
Atheroscler Plus
; 50: 1-9, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36643800
13.
Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors.
J Cardiovasc Dev Dis
; 9(7)2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877573
14.
Influence of lipid-lowering drugs on inflammation: what is yet to be done?
Arch Med Sci
; 18(4): 855-869, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35832698
15.
Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies.
J Cardiovasc Dev Dis
; 9(12)2022 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36547456
16.
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels.
J Cardiovasc Dev Dis
; 9(5)2022 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621838
17.
TNF-α Predicts Endothelial Function and Number of CD34+ Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure.
J Cardiovasc Dev Dis
; 9(8)2022 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005445
18.
Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.
Biomolecules
; 12(1)2021 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053174
19.
LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels.
J Cardiovasc Dev Dis
; 8(12)2021 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940537
20.
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options.
Ann Med
; 52(5): 162-177, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453609